# CRx-102 Osteoarthritis Multicenter Evaluation Trial

> **NCT00521989** · PHASE2 · TERMINATED · sponsor: **Zalicus** · enrollment: 279 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** CRx-102 (2.7/90)
- **DRUG:** Prednisolone
- **DRUG:** Placebo
- **DRUG:** CRx-102 (2.7/180)
- **DRUG:** CRx-102 (2.7/360)

## Key facts

- **NCT ID:** NCT00521989
- **Lead sponsor:** Zalicus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 279 (ACTUAL)
- **Why stopped:** CRx-102-006 study results, negative
- **Last updated:** 2014-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521989, "CRx-102 Osteoarthritis Multicenter Evaluation Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00521989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*